24 /100
LOW RISK
Score updated May 29, 2026

CLDX — Celldex Therapeutics, Inc. Dilution Risk Tracker

Track CLDX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CLDX — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
10
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for CLDX.
🔔 Track CLDX — Get forecast alerts →

💹 Market Data

Market Cap$2.49B
Shares Outstanding78.49M
Float72.46M
Cash$451.46M
Debt$1.91M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 3.4% shares (2025Q4 vs prior)
190 institutional holders · 74.77M shares
#1 WELLINGTON MANAGEMENT GROUP LLP 8.08M shares
#2 Kynam Capital Management, LP 5.94M shares
#3 BlackRock, Inc. 5.45M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest7.60M
Days to Cover9.4
% of Float10.5%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

No recent SEC insights

📰 Recent News

No recent news
Track CLDX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CLDX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for CLDX
📊 CLDX FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 CLDX Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.